This paper explores the economic incentives that oncologists face when deciding between oral and intravenous oncolytics and their impact on prescribing behavior.
Karen E. Van Nuys, PhD
Advertisement
Articles by Karen E. Van Nuys, PhD
Advertisement
Latest Updated Articles
- Practice Economics and the Decision to Prescribe Oral Oncolytics
Published: December 6th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5
